Several directors at pharma group Vernalis (VER) have backed a recent fundraising. Specialist writer Megan Boxall explains why she sees this as a positive for our buy recommendation.
Several directors at pharma group Vernalis (VER) have backed a recent fundraising. Specialist writer Megan Boxall explains why she sees this as a positive for our buy recommendation.